| abstract |
Described are compounds of Formula (1)or a pharmaceutically acceptable derivative, N-oxide, salt, hydrate, solvate, complex bioisostere, metabolite or prodrug thereof, the compound being a dual calpain-ROS inhibitor for the treatment of a disease mediated by ROS and/or calpain hyperactivity. |